Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 1;32(Web Server issue):W242-8.
doi: 10.1093/nar/gkh438.

PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level

Affiliations

PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level

Lucía Conde et al. Nucleic Acids Res. .

Abstract

We have developed a web tool, PupaSNP Finder (PupaSNP for short), for high-throughput searching for single nucleotide polymorphisms (SNPs) with potential phenotypic effect. PupaSNP takes as its input lists of genes (or generates them from chromosomal coordinates) and retrieves SNPs that could affect the conserved regions that the cellular machinery uses for the correct processing of genes (intron/exon boundaries or exonic splicing enhancers), predicted transcription factor binding sites (TFBS) and changes in amino acids in the proteins. The program uses the mapping of SNPs in the genome provided by Ensembl. Additionally, user-defined SNPs (not yet mapped in the genome) can be easily provided to the program. Also, additional functional information from Gene Ontology, OMIM and homologies in other model organisms is provided. In contrast to other programs already available, which focus only on SNPs with possible effect in the protein, PupaSNP includes SNPs with possible transcriptional effect. PupaSNP will be of significant help in studies of multifactorial disorders, where the use of functional SNPs will increase the sensitivity of identification of the genes responsible for the disease. The PupaSNP web interface is accessible through http://pupasnp.bioinfo.cnio.es.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A selection of results from PupaSNP. (A) List of genes and the corresponding transcripts with the SNPs mapping to the different regions, which include coding and 5′- and 3′-untranslated regions. For coding SNPs, the position within the transcript and the change produced (if any) is reported. (B) SNPs located in the promoter regions (in the example, a limit of 4000 bp was chosen). Disruptions of predicted TFBSs are listed. The validation status of the SNPs (‘no-info’, ‘by-submitter’, ‘by-frequency’, ‘by-cluster’; see dbSNP web page) is also provided. (C) SNPs located at exonic splice enhancers. The scores make reference to the closeness of the site to the motif. If the polymorphism gives a site with a worst score, this would, generally speaking, probably imply worst recognition of the site by the cellular machinery and, consequently, a putative alteration in the normal splicing process. When the cursor is over the gene name, additional information is displayed.

References

    1. Collins F.S., Green,E.D., Guttmacher,A.E. and Guyer,M.S. (2003) A vision for the future of genomics research. Nature, 422, 835–847. - PubMed
    1. Risch N.J. (2000) Searching for genetic determinants in the new millennium. Nature, 405, 847–856. - PubMed
    1. Botstein D. and Risch,N. (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet., 33, 228–237. - PubMed
    1. Badano J.L. and Katsanis,N. (2002) Human genetics and disease: beyond Mendel: an evolving view of human genetic disease transmission. Nature Rev. Genet., 3, 779–789. - PubMed
    1. Strittmatter W.J., Saunders,A.M., Schmechel,D., Pericak-Vance,M., Enghild,J., Salvesen,G.S. and Roses,A.D. (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl Acad. Sci., USA, 90, 1977–1981. - PMC - PubMed

Substances